Ardelyx (ARDX) EBITDA Margin (2013 - 2026)
Ardelyx (ARDX) reported EBITDA Margin of -9.78% for Q2 2026, up 4.31 percentage points from -14.09% a year earlier and up 23.96 percentage points from the prior quarter.
Ardelyx (ARDX) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ardelyx's EBITDA Margin came in at -7.12%, up 2.74 percentage points year-over-year; for FY2025, it came in at -9.31%, down 1.55 percentage points from FY2024.
- EBITDA Margin has a five-year change of +1152.04 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -7.76% in FY2024 (+42.04 pp), -49.80% in FY2023 (+70.24 pp), -120.05% in FY2022 (+1378.41 pp) and -1498.45% in FY2021 (-337.10 pp).
- Five-year quarterly EBITDA Margin spans a low of -5832.69% in Q1 2022 and a high of 27.77% in Q4 2022.
- Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of +12.95 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2023 (a gain of 5603.41 percentage points); the low point was Q1 2022 (a drop of 5354.02 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -33.74% (Q1 2026), 4.81% (Q4 2025) and 5.05% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Ardelyx | 778.63 Mn | -248.66 Mn | 115.12 Mn | -8.48% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.48% |
| Mar 31, 2026 | -32.07% |
| Dec 31, 2025 | 6.47% |
| Sep 30, 2025 | 7.27% |
| Jun 30, 2025 | -11.75% |
| Mar 31, 2025 | -45.35% |
| Dec 31, 2024 | 9.15% |
| Sep 30, 2024 | 4.87% |
| Jun 30, 2024 | -15.57% |
| Mar 31, 2024 | -48.87% |
| Dec 31, 2023 | -77.11% |
| Sep 30, 2023 | 15.41% |
| Jun 30, 2023 | -66.88% |
| Mar 31, 2023 | -220.10% |
| Dec 31, 2022 | 29.83% |
| Sep 30, 2022 | -415.10% |
| Jun 30, 2022 | -1,025.26% |
| Mar 31, 2022 | -5,819.44% |
| Dec 31, 2021 | -3,372.89% |
| Sep 30, 2021 | -3,570.33% |
Ardelyx EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();